Registry of Major Liver Resections Including ALPPS and Other Liver Resections in Two Stages
Launched by UNIVERSITY OF ZURICH · Aug 14, 2013
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
The ALPPS registry is accessible online through the data portal www.allps.net. Registered members recieve access through a member ID and password. Data submission is supported by the SECUTRIAL software, supported by the Clinical Trials center of the University of Zurich.
All data submitted are anonymized before entry through the SECUTRIAL Software. Administration of the registry data is performed through the Department of Visceral and Transplantation Surgery in the University Hospital Zurich and the Clinical Trials Center of the University of Zurich, Switzerland, in collaboration with the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All Patients who undergo the new ALPPS procedure
- • Patients undergoing any other modification of ALPPS like portal vein embolization (PVE) or banding of the liver with portal vein ligation or embolisation or other liver resection in two stages resembling ALPPS_
- • Male and Female patients 18 years to no limit
- • Prior registering the data, patient was informed and did not object to the use of his/her anonymized medical data in this registry
- Exclusion Criteria:
- • No exclusion criteria apply for a registry
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Pierre Alain Clavien, Prof, MD, PhD
Principal Investigator
University of Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials